Accelerating the Process Scale Up - Get it first time right

Free registration

First Name *

Last Name *

Email Address *

Phone Number *

Organization *

Job Title *

Street Address

City *

Zip/Postal Code

I want to receive updates and other offers from Ansys and its partners. I can unsubscribe at any time. Ansys Privacy Notice.

If you register for the content detailed on this page (the “Content”), you submit your personal information to ANSYS, Inc. and its subsidiaries and affiliates (collectively “Ansys”). Ansys uses your personal information in compliance with its Ansys Privacy Notice to deliver the Content and to send you communications and related information. Additionally, Ansys may share your information with its Channel Partners, as outlined in its privacy notice. Please know, Ansys is not affiliated with the entity hosting the Content.

Tues, 17 August, 2021 |

3:00 PM - 5:00 PM IST

With growing competition, pharma manufacturers must gear up to build competitive advantage to retain their market leadership. Computer Modelling and Simulation (CM&S) provides much-needed leverage to scale up production as they move from small pilot studies to progressively larger clinical trials, then finally into large-scale production of drugs.

Pharma manufacturing systems are highly variable with each system having different levels of interdependence and variability. Simulation helps untangle the chaos and bring out data backed solutions.

As per industry studies, some major areas where simulation aids pharma companies are:

Improved Manufacturing Process Efficiency: 4X reduction in product cost; 9X reduction in development cost
Improving Fidelity of Pharma Products
Reduce Time-To-Market: 2.5X reduction in number of change orders which eventually leads to 67% improvement in new product introduction rate

By enabling a confluence of industry leaders and simulation experts, this event will bring out various simulation led strategies aimed at reducing cost, accurately modelling and understanding process complexities while maintaining product differentiation and improving time to market of drugs.

Key Discussion Points:

Importance of Innovation in Pharma Manufacturing
Key Challenges Encountered by Pharma Manufacturing
Reducing Time-to-Market in bringing New Vaccine/Drug to the Patient
Making Drugs/Vaccines more Affordable for Indian Population
Maximizing patient safety during Vaccine/Drug Roll-out

Agenda:

TIME	SESSION
3:00 PM – 3:20 PM	Keynote : Cost & Time Reduction Focus to Build Competitive Advantage for Indian Pharma Sauri Gudlavalleti, Head R&D, Dr. Reddy's Laboratories
3:20 PM – 3:40 PM	Ansys Executive Presentation : Simulation Driven Innovation in Pharma Industry Thierry Marchal, Program Director - Healthcare Solutions, Ansys
3:40 PM – 4:00 PM	Customer Success Story : Role of simulation in accelerating pharmaceutical process scale-up and technology transfer Nandan Kulkarni, Director - Medical Devices, Cipla
4:00 PM – 4:45 PM	Fireside Chat : Simulation for Digital Transformation of Pharma Manufacturing Speakers : Hemant Punekar, Healthcare Expert- India, Ansys Birendra Kumar David, Director, Dr. Reddy's Laboratories Moderator : Viveka Roychowdhury, Editor, Express Pharma & Express Healthcare
4:47 PM – 4:50 PM	Concluding Remarks